Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Raphaël Clère-Jehl, Antoine Altdorfer et al.|The Lancet Infectious Diseases|2021

Cited by 344